Cite

HARVARD Citation

    Tan, Y. et al. (2017). Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study. Oncoimmunology. p. . [Online]. 
  
Back to record